Over the last 15-20 years, the UK has come to be seen by some in the global pharmaceutical industry as a problematic, low growth market which has erected many barriers to market access for new ...

A UK market access summit convened by IQVIA brought together pharma and NHS leaders to look at how working more closely – including more outcomes-based deals – could help UK life sciences ...

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Service ... In addition, in the UK, the launch of The Accelerated Access ...

Dublin, May 16, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Drugs Industry ... and technological advances. The analysis includes recent developments in the product portfolios of major companies, as ...

British money transfer firm Wise became the latest UK listed firm on Thursday to say that it intends to move its primary ...

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry (ABPI) calling up its members to speak on the record, ...

According to an analysis from Reuters ... British Pharmaceutical Industry found 2,687 links between the UK pharmaceutical industry and academia in 2022, compared with 1,134 in 2003.

along with a competitive landscape analysis, including regulatory scenarios, market drivers, restraints, and opportunities. Excipients in Pharmaceuticals: Global Markets to 2029: This report ...

More information: Shai Mulinari et al, Patterns of company misconduct, recidivism, and complaint resolution delays: A temporal analysis of UK pharmaceutical industry self‐regulation within the ...

Pharmaceutical market research analysis (PMRA) can validate a product's potential reach and market penetration capabilities. Investors use it to put a value on drug-making companies and their ...

Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's sweeping executive order to slash prescription drug prices would be difficult to ...